Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy with statins.

Helena Gylling1, Tatu A Miettinen

  • 1Department of Clinical Nutrition, University of Kuopio, Kuopio University Hospital, PL 1627, 70211 Kuopio, Finland.

Current Opinion in Investigational Drugs (London, England : 2000)
|December 25, 2002
PubMed
Summary

Statins are common cholesterol drugs. Combination therapies, including those with cholesterol absorption inhibitors, are effective for managing hypercholesterolemia when statins alone are insufficient.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High cholesterol absorption efficiency enhances proatherogenic properties of low-density lipoprotein particles.

Journal of internal medicine·2026
Same author

A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol.

EBioMedicine·2026
Same author

High cholesterol absorption efficiency increases the risk of the nonfatal and fatal atherosclerotic events.

Journal of lipid research·2026
Same author

High cholesterol absorption efficiency interferes with bile acid metabolism and cholesterol elimination from the body.

Journal of internal medicine·2025
Same author

Heart-healthy diets including phytostanol ester consumption to reduce the risk of atherosclerotic cardiovascular diseases. A clinical review.

Lipids in health and disease·2024
Same author

Inflammation, infection, and cardiovascular risk.

Lancet (London, England)·2024

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Lipid Metabolism

Background:

  • Statins are primary drugs for hypercholesterolemia, inhibiting cholesterol synthesis.
  • Certain patient groups, including those with familial hypercholesterolemia or combined hyperlipidemia, require combination treatments.
  • Intolerance or contraindications to statins necessitate alternative or add-on therapies.

Purpose of the Study:

  • To review combination therapies for hypercholesterolemia beyond standard statin monotherapy.
  • To discuss the mechanisms and efficacy of combining statins with agents affecting cholesterol absorption or bile acid binding.
  • To explore the role of other agents like fibrates, n-3 fatty acids, hormone replacement therapy, and niacin in combination with statins.

Main Methods:

  • Review of existing literature on statin combination therapies.
  • Analysis of mechanisms by which different agents enhance LDL cholesterol reduction.
  • Discussion of clinical considerations for expert-guided combination treatments.

Main Results:

  • Combining statins with cholesterol malabsorption inducers (e.g., plant stanol esters, ezetimibe) effectively lowers LDL cholesterol.
  • Combining statins with bile acid malabsorption agents (e.g., resins, guar gum) also inhibits compensatory cholesterol synthesis.
  • Combination therapy with fibrates requires expert lipidology supervision.

Conclusions:

  • Combination therapies offer enhanced lipid-lowering effects for specific patient populations.
  • Mechanisms involve inhibiting compensatory cholesterol synthesis pathways.
  • Careful consideration and expert guidance are crucial for optimizing combination treatment strategies.

Related Experiment Videos